News
09-30-2026, 12:50 PM
One of the major challenges in the treatment of the most common subtype of breast cancer (hormone receptor positive, HR+) is the emergence of resistance.
More... (https://www.news-medical.net/news/20260930/Nuclear-enzyme-discovery-unlocks-new-paths-to-combat-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20260930/Nuclear-enzyme-discovery-unlocks-new-paths-to-combat-breast-cancer.aspx)